christer fåhraeus

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
christer fåhraeus's trades of EQL Pharma AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-18 2025-02-17
S Sale
29,294
340.93
SEK3,109,212 		29,294 340.93 SEK3,109,212
2024-03-15 2024-03-15
S Sale
79,435
290.51
SEK3,628,805 		79,435 290.51 SEK3,628,805
2023-12-12 2023-12-12
S Sale
34,563
240.79
SEK3,182,262 		34,563 240.79 SEK3,182,262
2023-11-24 2023-11-23
S Sale
90,000
30.22
SEK2,719,800 		90,000 30.22 SEK2,719,800
2019-11-27 2019-11-25
B Purchase
4,495
13.15
SEK59,109 		4,495 13.15 SEK59,109
2019-07-23 2019-07-19
B Purchase
230,000
12.00
SEK2,760,000 		230,000 12.00 SEK2,760,000
2018-11-21 2018-11-21
B Purchase
26,543
6.00
SEK159,258 		26,543 6.00 SEK159,258
2018-11-16 2018-11-13
B Purchase
1,698,922
6.00
SEK10,193,532 		1,698,922 6.00 SEK10,193,532
2017-09-15 2017-09-15
B Purchase
10,300
11.74
SEK120,922 		10,300 11.74 SEK120,922